An unidentified whistleblower has filed a lawsuit against Amgen Inc. accusing the biotechnology company of illegal marketing of its blockbuster drugs Enbrel and Aranesp.
Wyeth, which co-markets Enbrel with Amgen, also was named as a defendant, along with wholesale drug distributor AmerisourceBergen Corp., online health-information provider WebMD Health Corp. and other defendants.
More at WSJ
No comments:
Post a Comment